Get an inside look at how McKesson partners with biopharma companies to power regulatory, payer and clinical decision making through real-world evidence.

McKesson’s Sarah Alwardt, vice president of Data Evidence and Insights Operations, discusses how collecting and analyzing real-world data for new oncology therapies can help biopharma companies:

• demonstrate value to payers and prescribers
• identify patient populations
• understand the potential market
• support regulatory needs for label approvals

McKesson.com/LifeSciences